Prostate Cancer - Results from #21660

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer - Abstract December 17, 2013

Prostate cancer with lytic bone metastases: (18)F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy - Abstract December 17, 2013

Detection of prostate cancer related copy number variations with SNP genotyping array - Abstract December 17, 2013

Retropubic versus robot-assisted laparoscopic prostatectomy for prostate cancer: A comparative study of postoperative complications - Abstract December 16, 2013

The role of radical prostatectomy in high-risk prostate cancer - Abstract December 13, 2013

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: The results of real life practice - Abstract December 13, 2013

Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of (1) H magnetic resonance spectroscopic imaging - Abstract December 13, 2013

'It's not like you just had a heart attack': Decision-making about active surveillance by men with localized prostate cancer - Abstract December 13, 2013

Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology - Abstract December 13, 2013

The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: A systematic review - Abstract December 13, 2013

Prostate-specific antigen growth rate constant after first-line cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: A monoinstitutional experience - Abstract December 13, 2013

New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions? - Abstract December 13, 2013

Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants - Abstract December 13, 2013

Radiation dosimetry of (18)F-flurocholine PET/CT studies in prostate cancer patients - Abstract December 13, 2013

Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study - Abstract December 13, 2013

Target detection: Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy - Abstract December 13, 2013

Meta-analysis of (11)C-choline and (18F)-choline PET/CT for management of patients with prostate cancer - Abstract December 13, 2013

The prostate cancer genome: Perspectives and potential - Abstract December 13, 2013

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment - Abstract December 13, 2013

Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score - Abstract December 12, 2013

Page 1084 of 1438